Daily Market Reports | Nov 22 2023
This story features ATLANTIC LITHIUM LIMITED., and other companies. For more info SHARE ANALYSIS: A11
An additional news report on the recommendation, valuation, forecast and opinion changes and updates for ASX-listed equities.
In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now added The Australian Broker Call *Extra* Edition, featuring additional sources of research and insights on ASX-listed stocks, also enlarging the number of stocks that make up the FNArena universe.
One key difference is the *Extra* Edition will not be updated daily, but merely "regularly" depending on availability of suitable quality content. As such, the *Extra* Edition tries to build a bridge between daily updates via the Australian Broker Call Report and ad hoc news stories, that are not always timely for investors hungry for the next information update.
Investors using the *Extra* Edition as a source of input for their own share market research should thus take into account that information after publication may not be up to date, or yet awaiting another update by FNArena's team of journalists.
Similar to The Australian Broker Call Report, this *Extra* Edition includes concise but limited reviews of research recently published by Stockbrokers and other experts, which should be considered as information concerning likely market behaviour rather than advice on the securities mentioned. Do not act on the contents of this Report without first reading the important information included at the end of this Report.
The Australian Broker Call *Extra* Edition is a summary that has been prepared independently of the sources identified. Readers will check the full text of the recommendations and consult a Licenced Advisor before making any investment decision.
The copyright of this Report is owned by the publisher. Readers will not copy, forward or disseminate this Report to any other person. For more vital information about the sources included, see the bottom of this Report.
COMPANIES DISCUSSED IN THIS ISSUE
Click on a symbol for fast access.
The number next to the symbol represents the number of brokers covering it for this report -(if more than 1)
A11 ABB AKE ALL ALQ ANZ BLD BRG CAI CAT CBA (2) CSL CTM DGL DYL ELD (2) IGO IPL LIC (2) MHJ MRM (2) MTS NHF NST NUF NWC OFX (2) REG RHC (2) RUL SDV STX SUN TLS (2) TPG
A11 ATLANTIC LITHIUM LIMITED.
New Battery Elements – Overnight Price: $0.53
Wilsons rates ((A11)) as Overweight (1) –
Atlantic Lithium has been granted prospecting licenses for the Bewadze and Senya Beraku sites. Wilsons notes little to no modern exploration has been undertaken across the now licensed areas, and Atlantic Lithium is planning extensive work to evaluate potential.
The broker considers this the latest in a stream of positive news from Atlantic Lithium, and sees the license approval as demonstrative of the Ghanian government's desire to support Atlantic Lithium's exploration efforts.
The Overweight rating and target price of 95 cents are retained.
This report was published on November 14, 2023.
Target price is $0.95 Current Price is $0.53 Difference: $0.425
If A11 meets the Wilsons target it will return approximately 81% (excluding dividends, fees and charges).
The company's fiscal year ends in June.
Forecast for FY24:
Wilsons forecasts a full year FY24 dividend of 0.00 cents and EPS of minus 0.40 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 131.25.
Forecast for FY25:
Wilsons forecasts a full year FY25 dividend of 0.00 cents and EPS of 0.00 cents.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
ABB AUSSIE BROADBAND LIMITED
Telecommunication – Overnight Price: $3.85
Wilsons rates ((ABB)) as Market Weight (3) –
Wilsons notes a number of levers at Aussie Broadband's disposal to accelerate organic and inorganic growth, not only delivering from strong first quarter broadband subscriber additions, but also the proposed Symbio ((SYM)) purchase and additional capital held by the company.
The broker sees the Symbio acquisition as earnings accretive, and notes there are likely further incremental merger and acquisition opportunities in the current market, with Aussie Broadband alluding to being progressed on a number of opportunities.
The Overweight rating is retained and the target price increases to $4.20 from $3.76.
This report was published on November 15, 2023.
Target price is $4.20 Current Price is $3.85 Difference: $0.35
If ABB meets the Wilsons target it will return approximately 9% (excluding dividends, fees and charges).
The company's fiscal year ends in June.
Forecast for FY24:
Wilsons forecasts a full year FY24 dividend of 0.00 cents and EPS of 14.30 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 26.92.
Forecast for FY25:
Wilsons forecasts a full year FY25 dividend of 0.00 cents and EPS of 22.40 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 17.19.
Market Sentiment: 0.5
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
AKE ALLKEM LIMITED
New Battery Elements – Overnight Price: $9.29
Canaccord Genuity rates ((AKE)) as Buy (1) –
Canaccord Genuity's assessment of the merger between Allkem and Livent is that it makes strategic sense.
While there is a roughly even split on net asset values, the broker says the attraction of higher multiples has fallen for now.
The broker suspects strategic windfalls and the possibility of higher trading multiples over the long term may convince investors to support the merger, which it considers to be "mostly fair".
Should the merger fall through, Canaccord Genuity spies strong upside for Allkem. Buy rating and $18.50 target price retained.
This report was published on November 14, 2023.
Target price is $18.50 Current Price is $9.29 Difference: $9.21
If AKE meets the Canaccord Genuity target it will return approximately 99% (excluding dividends, fees and charges).
Current consensus price target is $15.76, suggesting upside of 75.5%(ex-dividends)
Forecast for FY24:
Current consensus EPS estimate is 67.5, implying annual growth of -34.5%.
Current consensus DPS estimate is 2.0, implying a prospective dividend yield of 0.2%.
Current consensus EPS estimate suggests the PER is 13.3.
Forecast for FY25:
Current consensus EPS estimate is 95.6, implying annual growth of 41.6%.
Current consensus DPS estimate is 3.3, implying a prospective dividend yield of 0.4%.
Current consensus EPS estimate suggests the PER is 9.4.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
ALL ARISTOCRAT LEISURE LIMITED
Gaming – Overnight Price: $40.75
Jarden rates ((ALL)) as Upgrade to Buy from Overweight (1) –
On November 10, prior to FY23 results for Aristocrat Leisure on November 15, Jarden upgraded its rating to Buy from Overweight given ongoing market share gains across an elevated US gaming market. The target was also increased to $47 from $41.90.
Following the results, the target was increased further to $47.20 from $47 as revenue exceeded the broker's expectation by 2%, but was in line with consensus. Strong operating cash flow generation resulted in a stronger year-end cash balance.
Jarden's Buy rating was retained.
The analysts highlight Aristocrat Leisure offers above market earnings and operating free cash flow (FCF) growth, a high return on invested capital (ROIC) and a debt-free balance sheet with ample buyback support.
This report was published on November 17, 2023.
Target price is $47.20 Current Price is $40.75 Difference: $6.45
If ALL meets the Jarden target it will return approximately 16% (excluding dividends, fees and charges).
Current consensus price target is $45.24, suggesting upside of 11.7%(ex-dividends)
The company's fiscal year ends in September.
Forecast for FY24:
Jarden forecasts a full year FY24 dividend of 77.00 cents and EPS of 220.10 cents.
At the last closing share price the estimated dividend yield is 1.89%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 18.51.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 211.4, implying annual growth of -5.0%.
Current consensus DPS estimate is 68.9, implying a prospective dividend yield of 1.7%.
Current consensus EPS estimate suggests the PER is 19.2.
Forecast for FY25:
Jarden forecasts a full year FY25 dividend of 87.00 cents and EPS of 249.40 cents.
At the last closing share price the estimated dividend yield is 2.13%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 16.34.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 227.1, implying annual growth of 7.4%.
Current consensus DPS estimate is 74.2, implying a prospective dividend yield of 1.8%.
Current consensus EPS estimate suggests the PER is 17.8.
Market Sentiment: 0.9
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
ALQ ALS LIMITED
Industrial Sector Contractors & Engineers – Overnight Price: $12.26
Goldman Sachs rates ((ALQ)) as Buy (1) –
ALS Ltd's 1H underlying profit beat forecasts by Goldman Sachs and consensus by 2% and 1%, respectively, due to the performance of Life sciences, slightly offset by lower-than-expected Commodities revenue.
Also, growth in Environmental stayed strong, partially offset by slowdown in Pharmaceutical business, explains the broker.
Management guided to FY24 underlying profit of $310-325m, in line with Goldman Sachs estimates for $320m.
The broker's forecasts earnings changes are minimal, but the target falls to $13.70 from $14.10 on an adjusted multiple. The Buy rating is maintained.
This report was published on November 15, 2023.
Target price is $13.70 Current Price is $12.26 Difference: $1.44
If ALQ meets the Goldman Sachs target it will return approximately 12% (excluding dividends, fees and charges).
Current consensus price target is $11.94, suggesting downside of -2.4%(ex-dividends)
The company's fiscal year ends in March.
Forecast for FY24:
Goldman Sachs forecasts a full year FY24 dividend of 40.00 cents and EPS of 67.00 cents.
At the last closing share price the estimated dividend yield is 3.26%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 18.30.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 65.0, implying annual growth of 12.7%.
Current consensus DPS estimate is 38.9, implying a prospective dividend yield of 3.2%.
Current consensus EPS estimate suggests the PER is 18.8.
Forecast for FY25:
Goldman Sachs forecasts a full year FY25 dividend of 42.00 cents and EPS of 70.00 cents.
At the last closing share price the estimated dividend yield is 3.43%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 17.51.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 67.7, implying annual growth of 4.2%.
Current consensus DPS estimate is 40.6, implying a prospective dividend yield of 3.3%.
Current consensus EPS estimate suggests the PER is 18.1.
Market Sentiment: 0.3
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
ANZ ANZ GROUP HOLDINGS LIMITED
Banks – Overnight Price: $24.29
Jarden rates ((ANZ)) as Overweight (2) –
Following a review of ANZ Bank's FY23 "messy" result, Jarden believes intense competition is beginning to take its toll and contributed to the disappointing 2H headline net interest margin (NIM).
Deposit pricing/mix and liquidity/markets also impacted on the NIM, explain the analysts.
While cash profit was only -1.6% adrift of the consensus forecast, the broker highlights margins were well below estimates, offset partly by materially lower bad and doubtful debts (BDD) and higher other income.
After allowing for lower margins and higher costs (core costs grew by -4.5% year-on-year), Jarden lowers the FY24 and FY25 EPS forecast by -4.7% and -6.1%, respectively, and the target eases to $24.80 from $25.30.
A 94c final dividend was declared, up on the 81c expected by consensus, though the broker highlights the franking credit adjusted dividend remained steady.
This report was published on November 14, 2023.
Target price is $24.80 Current Price is $24.29 Difference: $0.51
If ANZ meets the Jarden target it will return approximately 2% (excluding dividends, fees and charges).
Current consensus price target is $26.28, suggesting upside of 8.5%(ex-dividends)
The company's fiscal year ends in September.
Forecast for FY24:
Jarden forecasts a full year FY24 dividend of 163.00 cents and EPS of 210.80 cents.
At the last closing share price the estimated dividend yield is 6.71%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 11.52.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 212.7, implying annual growth of -10.2%.
Current consensus DPS estimate is 161.0, implying a prospective dividend yield of 6.6%.
Current consensus EPS estimate suggests the PER is 11.4.
Forecast for FY25:
Jarden forecasts a full year FY25 dividend of 165.00 cents and EPS of 222.60 cents.
At the last closing share price the estimated dividend yield is 6.79%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 10.91.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 218.9, implying annual growth of 2.9%.
Current consensus DPS estimate is 158.6, implying a prospective dividend yield of 6.5%.
Current consensus EPS estimate suggests the PER is 11.1.
Market Sentiment: 0.3
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
BLD BORAL LIMITED
Building Products & Services – Overnight Price: $5.00
Jarden rates ((BLD)) as Overweight (2) –
Boral's earnings over July to October were better than Jarden expected due to good weather, steady volumes (good non-housing activity) and cost management across each business. Customers have also been receptive to recent price increases, explain the analysts.
Management FY24 earnings (EBIT) guidance was increased to $300-330m from $270-300m, 6% above the consensus forecast, notes the broker.
The broker sees upside risk to the operational margin, and now forecasts a 10.1% earnings margin (excluding property) in FY25, with an average of 12.4% across FY24-FY31.
The target rises to $5.35 from $4.95. Overweight.
This report was published on November 14, 2023.
Target price is $5.35 Current Price is $5.00 Difference: $0.35
If BLD meets the Jarden target it will return approximately 7% (excluding dividends, fees and charges).
Current consensus price target is $4.62, suggesting downside of -6.9%(ex-dividends)
The company's fiscal year ends in June.
Forecast for FY24:
Jarden forecasts a full year FY24 dividend of 0.00 cents and EPS of 19.20 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 26.04.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 17.2, implying annual growth of 20.1%.
Current consensus DPS estimate is 3.4, implying a prospective dividend yield of 0.7%.
Current consensus EPS estimate suggests the PER is 28.8.
Forecast for FY25:
Jarden forecasts a full year FY25 dividend of 13.90 cents and EPS of 23.20 cents.
At the last closing share price the estimated dividend yield is 2.78%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 21.55.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 21.7, implying annual growth of 26.2%.
Current consensus DPS estimate is 7.0, implying a prospective dividend yield of 1.4%.
Current consensus EPS estimate suggests the PER is 22.9.
Market Sentiment: -0.2
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
BRG BREVILLE GROUP LIMITED
Household & Personal Products – Overnight Price: $24.17
Goldman Sachs rates ((BRG)) as Buy (1) –
Goldman Sachs leaves its FY24 sales forecast unchanged for Breville Group, while trimming the earnings estimate on the likelihood of consumers seeking discounts in the upcoming holiday peak season.
However, the broker's target price rises to $25.70 from $24.50 after allowing for recent positive commentary at Breville's AGM and a promising read through from recent results by overseas peer De Longhi.
The analysts also note a strong 3Q for Chinese export growth regarding small appliances, which included small kitchen appliances.
The Buy rating is retained.
This report was published on November 15, 2023.
Target price is $25.70 Current Price is $24.17 Difference: $1.53
If BRG meets the Goldman Sachs target it will return approximately 6% (excluding dividends, fees and charges).
Current consensus price target is $26.40, suggesting upside of 9.9%(ex-dividends)
The company's fiscal year ends in June.
Forecast for FY24:
Goldman Sachs forecasts a full year FY24 dividend of 34.00 cents and EPS of 85.00 cents.
At the last closing share price the estimated dividend yield is 1.41%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 28.44.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 84.9, implying annual growth of 9.9%.
Current consensus DPS estimate is 32.9, implying a prospective dividend yield of 1.4%.
Current consensus EPS estimate suggests the PER is 28.3.
Forecast for FY25:
Goldman Sachs forecasts a full year FY25 dividend of 37.00 cents and EPS of 95.00 cents.
At the last closing share price the estimated dividend yield is 1.53%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 25.44.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 97.4, implying annual growth of 14.7%.
Current consensus DPS estimate is 37.5, implying a prospective dividend yield of 1.6%.
Current consensus EPS estimate suggests the PER is 24.7.
Market Sentiment: 0.7
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
CAI CALIDUS RESOURCES LIMITED
Gold & Silver – Overnight Price: $0.18
Canaccord Genuity rates ((CAI)) as Upgrade to Speculative Buy from Hold (1) –
Canaccord Genuity's site tour of Calidus Resources' Warrawoona and Haoma gold interests appears to have pleased the broker.
The broker spies relief for the company's staff, grade reconciliation and water challenges as extra higher-grade feed from Haoma JV boosts an improvement from Warranoona now the Cuban pit cutback has been completed.
The company closed the September quarter with cash and equivalents of $15m and repaid $6m in debt, leaving debt of $75m. The company's hedge position also reduced.
The broker conjectures that the company is trying to renegotiate its repayment schedule and/or hedging obligations given the balance sheet is likely to be tested prior to a likely recovery in the March quarter, and the broker is awaiting updates.
Rating is raised to Speculative Buy from Hold. Target price jumps to 30c from 15c, as the broker unwinds its risk weighting.
This report was published on November 15, 2023.
Target price is $0.30 Current Price is $0.18 Difference: $0.12
If CAI meets the Canaccord Genuity target it will return approximately 67% (excluding dividends, fees and charges).
The company's fiscal year ends in June.
Forecast for FY24:
Canaccord Genuity forecasts a full year FY24 dividend of 0.00 cents and EPS of 2.00 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 9.00.
Forecast for FY25:
Canaccord Genuity forecasts a full year FY25 dividend of 0.00 cents and EPS of 7.00 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 2.57.
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
CAT CATAPULT GROUP INTERNATIONAL LIMITED
Medical Equipment & Devices – Overnight Price: $1.12
Canaccord Genuity rates ((CAT)) as Buy (1) –
Catapult International's September-half result appears to have pleased Canaccord Genuity, the company logging revenue growth of 21% and a profit uplift of 35%, retaining its long-term margin target of 80%.
Management reiterated guidance for 30% profit margins over the long term and incremental free cash flow margins of more than 30% in the short term.
The broker considers Catapult to be at an inflection point as it moves through free cash flow breakeven. FY24 and FY25 EPS forecasts are steady.
Buy rating retained. Target price rises to $1.70 from $1.60.
This report was published on November 15, 2023.
Target price is $1.70 Current Price is $1.12 Difference: $0.575
If CAT meets the Canaccord Genuity target it will return approximately 51% (excluding dividends, fees and charges).
The company's fiscal year ends in March.
Forecast for FY24:
Canaccord Genuity forecasts a full year FY24 dividend of 0.00 cents and EPS of minus 11.01 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 10.22.
Forecast for FY25:
Canaccord Genuity forecasts a full year FY25 dividend of 0.00 cents and EPS of minus 6.18 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 18.20.
This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
CBA COMMONWEALTH BANK OF AUSTRALIA
Banks – Overnight Price: $103.70
Goldman Sachs rates ((CBA)) as Sell (5) –
CommBank's 1Q pre-provision operating profit (PPOP) was in line with Goldman Sachs forecast, while bad and doubtful debts (BDD) were lower than expected. The CET1 ratio of 11.8% was also broadly in line with the broker's forecast.
The target falls to $81.64 from $81.68 on minor forecast changes. The Sell rating is maintained as Goldman Sachs doesn't believe the current value premium versus peers is deserved.
The broker also thinks the bank's business mix leaves it more exposed to the current competitive environment.
This report was published on November 15, 2023.
Target price is $81.64 Current Price is $103.70 Difference: minus $22.06 (current price is over target).
If CBA meets the Goldman Sachs target it will return approximately minus 21% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $90.45, suggesting downside of -12.6%(ex-dividends)
The company's fiscal year ends in June.
Forecast for FY24:
Goldman Sachs forecasts a full year FY24 dividend of 450.00 cents and EPS of 560.00 cents.
At the last closing share price the estimated dividend yield is 4.34%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 18.52.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 567.2, implying annual growth of -6.1%.
Current consensus DPS estimate is 457.7, implying a prospective dividend yield of 4.4%.
Current consensus EPS estimate suggests the PER is 18.2.
Forecast for FY25:
Goldman Sachs forecasts a full year FY25 dividend of 450.00 cents and EPS of 546.00 cents.
At the last closing share price the estimated dividend yield is 4.34%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 18.99.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 583.9, implying annual growth of 2.9%.
Current consensus DPS estimate is 469.5, implying a prospective dividend yield of 4.5%.
Current consensus EPS estimate suggests the PER is 17.7.
Market Sentiment: -0.5
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Jarden rates ((CBA)) as Underweight (4) –
CommBank's September-quarter cash profit outpaced consensus by 3% and Jarden's forecasts by 3.5% due to lower than expected bad and doubtful debts, which more than offset a slight miss on core earnings due to softness in net interest margins.
Management advised it would continue to focus on shareholder returns over building mortgage market share.
EPS forecasts rise 1% in FY24; and 0.5% in FY25. Underweight rating and $98 target price retained.
This report was published on November 14, 2023.
Target price is $98.00 Current Price is $103.70 Difference: minus $5.7 (current price is over target).
If CBA meets the Jarden target it will return approximately minus 5% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $90.45, suggesting downside of -12.6%(ex-dividends)
The company's fiscal year ends in June.
Forecast for FY24:
Jarden forecasts a full year FY24 dividend of 450.00 cents and EPS of 561.00 cents.
At the last closing share price the estimated dividend yield is 4.34%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 18.48.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 567.2, implying annual growth of -6.1%.
Current consensus DPS estimate is 457.7, implying a prospective dividend yield of 4.4%.
Current consensus EPS estimate suggests the PER is 18.2.
Forecast for FY25:
Jarden forecasts a full year FY25 dividend of 452.00 cents and EPS of 569.00 cents.
At the last closing share price the estimated dividend yield is 4.36%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 18.22.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 583.9, implying annual growth of 2.9%.
Current consensus DPS estimate is 469.5, implying a prospective dividend yield of 4.5%.
Current consensus EPS estimate suggests the PER is 17.7.
Market Sentiment: -0.5
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
CSL CSL LIMITED
Pharmaceuticals & Biotech/Lifesciences – Overnight Price: $256.80
Goldman Sachs rates ((CSL)) as Upgrade to Buy from Neutral (1) –
Due to a sharp improvement in Goldman Sachs return on invested capital (ROIC) forecast, and historically-high earnings growth, it's felt CSL is now entering a period of more capital-efficient growth.
The historical correlation between CSL valuation and forward returns is set to return, suggests the broker, after the relationship broke down over FY22/23 due to a multiple de-rate.
The broker's rating is upgraded to Buy from Neutral and the target increases to $307 from $296.
This report was published on November 15, 2023.
Target price is $307.00 Current Price is $256.80 Difference: $50.2
If CSL meets the Goldman Sachs target it will return approximately 20% (excluding dividends, fees and charges).
Current consensus price target is $329.70, suggesting upside of 27.6%(ex-dividends)
The company's fiscal year ends in June.
Forecast for FY24:
Goldman Sachs forecasts a full year FY24 dividend of 407.18 cents and EPS of 835.47 cents.
At the last closing share price the estimated dividend yield is 1.59%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 30.74.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 951.2, implying annual growth of N/A.
Current consensus DPS estimate is 415.2, implying a prospective dividend yield of 1.6%.
Current consensus EPS estimate suggests the PER is 27.2.
Forecast for FY25:
Goldman Sachs forecasts a full year FY25 dividend of 465.99 cents and EPS of 957.62 cents.
At the last closing share price the estimated dividend yield is 1.81%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 26.82.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 1220.4, implying annual growth of 28.3%.
Current consensus DPS estimate is 535.5, implying a prospective dividend yield of 2.1%.
Current consensus EPS estimate suggests the PER is 21.2.
This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.9
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
CTM CENTAURUS METALS LIMITED
Nickel – Overnight Price: $0.52
Canaccord Genuity rates ((CTM)) as Speculative Buy (1) –
The definitive feasibility study for Centaurus Metals' Jaguar nickel sulphide project has been further delayed, and is now expected in the March quarter. The extension will allow for completion of capital and operating cost estimates, which Canaccord Genuity considers crucial.
With the broker already modelling a December quarter final investment decision, now in line with the company's delayed schedule, there is no change to Canaccord Genuity's outlook. The broker welcomes the "high degree of rigor and a considered approach" being taken.
The Speculative Buy rating is retained and the target price decreases to $1.40 from $1.60.
This report was published on November 13, 2023.
Target price is $1.40 Current Price is $0.52 Difference: $0.88
If CTM meets the Canaccord Genuity target it will return approximately 169% (excluding dividends, fees and charges).
The company's fiscal year ends in December.
Forecast for FY23:
Canaccord Genuity forecasts a full year FY23 dividend of 0.00 cents and EPS of minus 4.80 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 10.83.
Forecast for FY24:
Canaccord Genuity forecasts a full year FY24 dividend of 0.00 cents and EPS of minus 1.80 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 28.89.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
DGL DGL GROUP LIMITED
Commercial Services & Supplies – Overnight Price: $0.88
Canaccord Genuity rates ((DGL)) as Buy (1) –
DGL Group's AGM trading update met guidance, the company's diverse operations cushioning it from economic headwinds and volatile commodity and a forecast decline in crop production.
Meanwhile, Australian and New Zealand labour markets are easing, observes Canaccord Genuity, the company boasts a strong balance sheet and the company's strategic growth plans are on schedule.
No specific guidance was provided. The buyback has been paused, resulting in a 7% and 5% increase in FY24 and FY25 EPS forecasts.
Buy rating and $1.70 target price retained.
This report was published on November 15, 2023.
Target price is $1.70 Current Price is $0.88 Difference: $0.825
If DGL meets the Canaccord Genuity target it will return approximately 94% (excluding dividends, fees and charges).
Current consensus price target is $0.99, suggesting upside of 12.5%(ex-dividends)
The company's fiscal year ends in June.
Forecast for FY24:
Canaccord Genuity forecasts a full year FY24 dividend of 0.00 cents and EPS of 8.30 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 10.54.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 8.1, implying annual growth of 19.3%.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 10.9.
Forecast for FY25:
Canaccord Genuity forecasts a full year FY25 dividend of 0.00 cents and EPS of 10.10 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 8.66.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 9.6, implying annual growth of 18.5%.
Current consensus DPS estimate is 0.7, implying a prospective dividend yield of 0.8%.
Current consensus EPS estimate suggests the PER is 9.2.
Market Sentiment: 0.7
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
DYL DEEP YELLOW LIMITED
Uranium – Overnight Price: $1.22
Canaccord Genuity rates ((DYL)) as Initiation of coverage with Speculative Buy (1) –
With one of the largest uranium resources on the ASX, Deep Yellow is working to establish a multi-mine company with production capacity over 10m pounds per annum, at a time when nuclear generation growth is surpassing expectations, says Canaccord Genuity.
With Canaccord Genuity believing uranium spot prices are insufficient to stimulate the necessary level of development, the broker estimates every US$5 per pound change in uranium pricing would equate to a 20 cent change to Deep Yellow's share price.
The broker initiates with a Speculative Buy rating and a target price of $1.44.
This report was published on November 14, 2023.
Target price is $1.44 Current Price is $1.22 Difference: $0.22
If DYL meets the Canaccord Genuity target it will return approximately 18% (excluding dividends, fees and charges).
The company's fiscal year ends in June.
Forecast for FY23:
Canaccord Genuity forecasts a full year FY23 dividend of 0.00 cents and EPS of minus 1.50 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 81.33.
Forecast for FY24:
Canaccord Genuity forecasts a full year FY24 dividend of 0.00 cents and EPS of minus 1.20 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 101.67.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
ELD ELDERS LIMITED
Agriculture – Overnight Price: $7.21
Moelis rates ((ELD)) as Buy (1) –
Elders's FY23 result nosed out Moelis's estimates after falling at the mid point of guidance.
The broker appreciates the company's strong operating cash flow and new FY25 cost-out target.
Looking forward, dry weather forecasts are fostering caution among growers, which will likely result in lower crop plantings, but Elders expects gross margins will rise as input costs normalise.
Otherwise, the company expects cattle and sheep volumes to remain strong, which should dampen prices, and for summer cropping inputs to remain well bid.
Growth from acquisitions continues to help balance out pressure on livestock earnings observes the broker.
Hold rating retained. Target price rises to $7.92 a share from $7.45.
This report was published on November 13, 2023.
Target price is $7.92 Current Price is $7.21 Difference: $0.71
If ELD meets the Moelis target it will return approximately 10% (excluding dividends, fees and charges).
Current consensus price target is $7.73, suggesting upside of 7.8%(ex-dividends)
The company's fiscal year ends in September.
Forecast for FY24:
Moelis forecasts a full year FY24 dividend of 27.00 cents and EPS of 53.90 cents.
At the last closing share price the estimated dividend yield is 3.74%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 13.38.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 59.8, implying annual growth of -7.2%.
Current consensus DPS estimate is 38.1, implying a prospective dividend yield of 5.3%.
Current consensus EPS estimate suggests the PER is 12.0.
Forecast for FY25:
Moelis forecasts a full year FY25 dividend of 28.80 cents and EPS of 57.60 cents.
At the last closing share price the estimated dividend yield is 3.99%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 12.52.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 67.0, implying annual growth of 12.0%.
Current consensus DPS estimate is 41.1, implying a prospective dividend yield of 5.7%.
Current consensus EPS estimate suggests the PER is 10.7.
Market Sentiment: 0.2
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Wilsons rates ((ELD)) as Market Weight (3) –
Elders' FY23 result met revised guidance but was down sharply year on year observes Wilsons, the broker considering the result to be mixed.
No explicit guidance was provided but the broker expects pressure will continue on livestock and crop input prices, dampening earnings.
On the upside, the company delivered good cash flow and guided to cost cuts in FY24.
Market Weight rating. Target price rises to $7.02 from $6.22.
This report was published on November 14, 2023.
Target price is $7.02 Current Price is $7.21 Difference: minus $0.19 (current price is over target).
If ELD meets the Wilsons target it will return approximately minus 3% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $7.73, suggesting upside of 7.8%(ex-dividends)
The company's fiscal year ends in September.
Forecast for FY24:
Wilsons forecasts a full year FY24 dividend of 35.00 cents and EPS of 60.40 cents.
At the last closing share price the estimated dividend yield is 4.85%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 11.94.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 59.8, implying annual growth of -7.2%.
Current consensus DPS estimate is 38.1, implying a prospective dividend yield of 5.3%.
Current consensus EPS estimate suggests the PER is 12.0.
Forecast for FY25:
Wilsons forecasts a full year FY25 dividend of 38.00 cents and EPS of 68.90 cents.
At the last closing share price the estimated dividend yield is 5.27%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 10.46.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 67.0, implying annual growth of 12.0%.
Current consensus DPS estimate is 41.1, implying a prospective dividend yield of 5.7%.
Current consensus EPS estimate suggests the PER is 10.7.
Market Sentiment: 0.2
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
IGO IGO LIMITED
Nickel – Overnight Price: $9.18
Canaccord Genuity rates ((IGO)) as Sell (5) –
IGO acquired Cosmos via its $1.26bn purchase of Western Areas in 2022, one of the main attractions of the deal, but the project has suffered cost overruns (-$556m) and production delays, observes Canaccord Genuity.
The broker says the company may have to canvass the possibility the asset should be shut down before being turned on.
An Independent Review is under way and the broker observes earnings (EBITDA) are in structural decline and spot lithium prices are plunging.
Sell rating retained. Target price falls to $8 from $9.50.
This report was published on November 14, 2023.
Target price is $8.00 Current Price is $9.18 Difference: minus $1.18 (current price is over target).
If IGO meets the Canaccord Genuity target it will return approximately minus 13% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $12.54, suggesting upside of 37.9%(ex-dividends)
The company's fiscal year ends in June.
Forecast for FY24:
Canaccord Genuity forecasts a full year FY24 dividend of 28.00 cents and EPS of 119.00 cents.
At the last closing share price the estimated dividend yield is 3.05%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 7.71.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 132.4, implying annual growth of 82.6%.
Current consensus DPS estimate is 21.0, implying a prospective dividend yield of 2.3%.
Current consensus EPS estimate suggests the PER is 6.9.
Forecast for FY25:
Canaccord Genuity forecasts a full year FY25 dividend of 35.00 cents and EPS of 100.00 cents.
At the last closing share price the estimated dividend yield is 3.81%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 9.18.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 144.1, implying annual growth of 8.8%.
Current consensus DPS estimate is 36.7, implying a prospective dividend yield of 4.0%.
Current consensus EPS estimate suggests the PER is 6.3.
Market Sentiment: 0.5
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
IPL INCITEC PIVOT LIMITED
Agriculture – Overnight Price: $2.84
Jarden rates ((IPL)) as Neutral (3) –
FY23 Explosives earnings performed strongly, according to Jarden, particularly in Australia, though Fertiliser earnings are still being negatively impacted by operational issues and falling prices for diammonium phosphate (DAP).
Overall, the FY23 result slightly exceeded the broker's forecasts. A $1bn of capital return is contingent on sale approval for the Waggaman ammonia operation in Louisiana, but the broker thinks this outcome was already expected by the market.
Whilst FY23 gearing remains below management's targeted range, the analysts welcome further deleveraging over FY24 of (potentially) $249m, using a portion of the Waggaman proceeds.
The target falls to $2.70 from $2.85. Neutral.
This report was published on November 14, 2023.
Target price is $2.70 Current Price is $2.84 Difference: minus $0.14 (current price is over target).
If IPL meets the Jarden target it will return approximately minus 5% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $3.19, suggesting upside of 13.6%(ex-dividends)
The company's fiscal year ends in September.
Forecast for FY24:
Jarden forecasts a full year FY24 dividend of 11.70 cents and EPS of 23.30 cents.
At the last closing share price the estimated dividend yield is 4.12%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 12.19.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 22.0, implying annual growth of -23.7%.
Current consensus DPS estimate is 13.2, implying a prospective dividend yield of 4.7%.
Current consensus EPS estimate suggests the PER is 12.8.
Forecast for FY25:
Jarden forecasts a full year FY25 dividend of 10.70 cents and EPS of 21.30 cents.
At the last closing share price the estimated dividend yield is 3.77%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 13.33.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 19.7, implying annual growth of -10.5%.
Current consensus DPS estimate is 9.6, implying a prospective dividend yield of 3.4%.
Current consensus EPS estimate suggests the PER is 14.3.
Market Sentiment: 0.3
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
LIC LIFESTYLE COMMUNITIES LIMITED
Aged Care & Seniors – Overnight Price: $17.17
Canaccord Genuity rates ((LIC)) as Hold (3) –
Lifestyle Communities' AGM commentary appeared to please Canaccord Genuity, management advising 420 homes had been sold and were awaiting settlement.
The company is approaching peak development spend, and is forecast to shift into a cash recovery phase over the next year. The broker observes new home sales will continue to be skewed to the June half.
Hold recommendation and $17 target retained.
This report was published on November 14, 2023.
Target price is $17.00 Current Price is $17.17 Difference: minus $0.17 (current price is over target).
If LIC meets the Canaccord Genuity target it will return approximately minus 1% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $18.37, suggesting upside of 5.8%(ex-dividends)
Forecast for FY24:
Current consensus EPS estimate is 69.9, implying annual growth of -11.3%.
Current consensus DPS estimate is 13.0, implying a prospective dividend yield of 0.7%.
Current consensus EPS estimate suggests the PER is 24.8.
Forecast for FY25:
Current consensus EPS estimate is 95.3, implying annual growth of 36.3%.
Current consensus DPS estimate is 17.3, implying a prospective dividend yield of 1.0%.
Current consensus EPS estimate suggests the PER is 18.2.
Market Sentiment: 0.3
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Goldman Sachs rates ((LIC)) as Buy (1) –
A trading update at Lifestyle Communities' AGM was in line with forecasts by Goldman Sachs.
The broker believes settlements will begin to ramp-up substantially from the 2H onwards, helping to ease balance sheet pressure, and driving the business towards the upper end of medium-term settlement guidance.
Just as Lifestyle Communities enters this ramp-up for both settlements and cash flow, the analyst suggests the property cycle is moving to a tailwind from a headwind.
This view is based on management commentary around time-on-market, and homes sold and awaiting settlement. Buy. Target $25.25.
This report was published on November 15, 2023.
Target price is $25.25 Current Price is $17.17 Difference: $8.08
If LIC meets the Goldman Sachs target it will return approximately 47% (excluding dividends, fees and charges).
Current consensus price target is $18.37, suggesting upside of 5.8%(ex-dividends)
The company's fiscal year ends in June.
Forecast for FY24:
Goldman Sachs forecasts a full year FY24 dividend of 17.10 cents and EPS of 79.40 cents.
At the last closing share price the estimated dividend yield is 1.00%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 21.62.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 69.9, implying annual growth of -11.3%.
Current consensus DPS estimate is 13.0, implying a prospective dividend yield of 0.7%.
Current consensus EPS estimate suggests the PER is 24.8.
Forecast for FY25:
Goldman Sachs forecasts a full year FY25 dividend of 21.20 cents and EPS of 115.30 cents.
At the last closing share price the estimated dividend yield is 1.23%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 14.89.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 95.3, implying annual growth of 36.3%.
Current consensus DPS estimate is 17.3, implying a prospective dividend yield of 1.0%.
Current consensus EPS estimate suggests the PER is 18.2.
Market Sentiment: 0.3
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
MHJ MICHAEL HILL INTERNATIONAL LIMITED
Luxury – Overnight Price: $0.81
Jarden rates ((MHJ)) as Overweight (2) –
Michael Hill's trading update for the first 19 weeks of FY24 revealed a slowing in retail business, observes Jarden, although the company cites outperformance in the weaker market.
Management reports margin contraction as the market reaches for promotions and Jarden advises this situation will worsen should the market weaken further.
Earnings forecasts are cut sharply.
Overweight rating retained, the broker considering the company to be well positioned to benefit from a market recovery. Target price falls to NZ$1.15 from NZ$1.25.
This report was published on November 14, 2023.
Current Price is $0.81. Target price not assessed.
The company's fiscal year ends in June.
Forecast for FY24:
Jarden forecasts a full year FY24 dividend of 7.50 cents and EPS of 8.70 cents.
At the last closing share price the estimated dividend yield is 9.24%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 9.33.
Forecast for FY25:
Jarden forecasts a full year FY25 dividend of 7.50 cents and EPS of 10.00 cents.
At the last closing share price the estimated dividend yield is 9.24%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 8.12.
Market Sentiment: 0.5
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
MRM MMA OFFSHORE LIMITED
Energy Sector Contracting – Overnight Price: $1.52
Moelis rates ((MRM)) as Buy (1) –
MMA Offshore has provided guidance for its first half, with anticipated earnings of $55-60m exceeding Moelis' expectations by 56% at the midpoint. The range also suggests 79% growth year-on-year.
According to the company, strong activity across all key markets in the first four months of the financial year has driven strong contributions across all divisions, and the company is in a solid contracted revenue position for the remainder of the first half.
The Buy rating is retained and the target price increases to $1.90 from $1.65.
This report was published on November 16, 2023.
Target price is $1.90 Current Price is $1.52 Difference: $0.38
If MRM meets the Moelis target it will return approximately 25% (excluding dividends, fees and charges).
The company's fiscal year ends in June.
Forecast for FY24:
Moelis forecasts a full year FY24 dividend of 2.60 cents and EPS of 12.10 cents.
At the last closing share price the estimated dividend yield is 1.71%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 12.56.
Forecast for FY25:
Moelis forecasts a full year FY25 dividend of 3.10 cents and EPS of 14.80 cents.
At the last closing share price the estimated dividend yield is 2.04%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 10.27.
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Moelis rates ((MRM)) as Initiation of coverage with Buy (1) –
Moelis initiates coverage of marine and subsea services company MMA Offshore with a Buy rating and $1.65 target price.
Moelis observes vessel utilisation is on the rise and expects a shortfall in vessel supply will continue, spurring building demand.
As a result, better day rates and utilisation should yield strong operating leverage, says the broker.
Moelis observes the company enjoys a diverse revenue base and a balance sheet ready for M&A.
This report was published on November 14, 2023.
Target price is $1.65 Current Price is $1.52 Difference: $0.13
If MRM meets the Moelis target it will return approximately 9% (excluding dividends, fees and charges).
The company's fiscal year ends in June.
Forecast for FY24:
Moelis forecasts a full year FY24 dividend of 2.60 cents and EPS of 12.10 cents.
At the last closing share price the estimated dividend yield is 1.71%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 12.56.
Forecast for FY25:
Moelis forecasts a full year FY25 dividend of 3.10 cents and EPS of 14.80 cents.
At the last closing share price the estimated dividend yield is 2.04%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 10.27.
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
MTS METCASH LIMITED
Food, Beverages & Tobacco – Overnight Price: $3.67
Jarden rates ((MTS)) as Overweight (2) –
From late-November, for a cost of -$101.5m, Metcash will lift its stake in total Tools to 100% from 85%, an outcome Jarden had already anticipated in forecasts.
The broker approves of the transaction which provides access to a higher margin, specialty retailer at a discount to the existing group multiple.
The Overweight rating and $4.40 target are retained.
This report was published on November 14, 2023.
Target price is $4.40 Current Price is $3.67 Difference: $0.73
If MTS meets the Jarden target it will return approximately 20% (excluding dividends, fees and charges).
Current consensus price target is $4.10, suggesting upside of 11.7%(ex-dividends)
The company's fiscal year ends in April.
Forecast for FY24:
Jarden forecasts a full year FY24 dividend of 23.00 cents and EPS of 32.60 cents.
At the last closing share price the estimated dividend yield is 6.27%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 11.26.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 29.9, implying annual growth of 11.5%.
Current consensus DPS estimate is 20.6, implying a prospective dividend yield of 5.6%.
Current consensus EPS estimate suggests the PER is 12.3.
Forecast for FY25:
Jarden forecasts a full year FY25 dividend of 24.00 cents and EPS of 33.50 cents.
At the last closing share price the estimated dividend yield is 6.54%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 10.96.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 29.4, implying annual growth of -1.7%.
Current consensus DPS estimate is 20.7, implying a prospective dividend yield of 5.6%.
Current consensus EPS estimate suggests the PER is 12.5.
Market Sentiment: 0.3
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
NHF NIB HOLDINGS LIMITED
Insurance – Overnight Price: $7.45
Jarden rates ((NHF)) as Neutral (3) –
Jarden was pleased by revenue trends for the first four months of FY24 across private health insurance-related segments, though a weaker Travel outlook revealed during nib Holdings' AGM disappointed.
Even after adjusting for the loss of the Qantas Airways ((QAN)) contract, underlying Travel revenue growth of 13.2% was still well below the broker's 26% 1H growth forecast.
The analysts make only minor changes to forecast earnings and the Neutral rating and $8.00 target are unchanged.
This report was published on November 10, 2023.
Target price is $8.00 Current Price is $7.45 Difference: $0.55
If NHF meets the Jarden target it will return approximately 7% (excluding dividends, fees and charges).
Current consensus price target is $8.26, suggesting upside of 10.9%(ex-dividends)
The company's fiscal year ends in June.
Forecast for FY24:
Jarden forecasts a full year FY24 dividend of 29.00 cents and EPS of 41.50 cents.
At the last closing share price the estimated dividend yield is 3.89%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 17.95.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 45.3, implying annual growth of 9.4%.
Current consensus DPS estimate is 30.1, implying a prospective dividend yield of 4.0%.
Current consensus EPS estimate suggests the PER is 16.4.
Forecast for FY25:
Jarden forecasts a full year FY25 dividend of 30.00 cents and EPS of 47.10 cents.
At the last closing share price the estimated dividend yield is 4.03%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 15.82.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 48.6, implying annual growth of 7.3%.
Current consensus DPS estimate is 31.4, implying a prospective dividend yield of 4.2%.
Current consensus EPS estimate suggests the PER is 15.3.
Market Sentiment: 0.5
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
NST NORTHERN STAR RESOURCES LIMITED
Gold & Silver – Overnight Price: $11.86
Jarden rates ((NST)) as Initiation of coverage with Overweight (2) –
Northern Star Resources is one of the ten largest gold companies globally, when measured both in ounces produced and market capitalisation, highlights Jarden.
The broker has initiated research coverage with an Overweight rating and 12-month target price of $13.60.
Jarden finds Northern Star is attractively priced on an absolute basis and relative to both global and domestic peers.
The balance sheet, with a net cash position of $284m, is capable of funding an upcoming elevated period of capital expenditure, while still maintaining a history of strong shareholder returns, highlight the analysts.
The Kalgoorlie Consolidated Gold Mines (KCGM) asset accounts for almost two thirds of Jarden’s total valuation for Northern Star.
KCGM is considered a scarce investment opportunity, given it is a true Tier-1 asset, located in a Tier-1 jurisdiction with abundant optionality and ongoing exploration prospects, explains the broker.
This report was published on November 10, 2023.
Target price is $13.60 Current Price is $11.86 Difference: $1.74
If NST meets the Jarden target it will return approximately 15% (excluding dividends, fees and charges).
Current consensus price target is $12.75, suggesting upside of 5.5%(ex-dividends)
The company's fiscal year ends in June.
Forecast for FY24:
Jarden forecasts a full year FY24 dividend of 23.00 cents and EPS of 35.20 cents.
At the last closing share price the estimated dividend yield is 1.94%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 33.69.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 50.9, implying annual growth of 0.2%.
Current consensus DPS estimate is 31.8, implying a prospective dividend yield of 2.6%.
Current consensus EPS estimate suggests the PER is 23.7.
Forecast for FY25:
Jarden forecasts a full year FY25 dividend of 26.00 cents and EPS of 61.80 cents.
At the last closing share price the estimated dividend yield is 2.19%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 19.19.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 70.9, implying annual growth of 39.3%.
Current consensus DPS estimate is 35.6, implying a prospective dividend yield of 2.9%.
Current consensus EPS estimate suggests the PER is 17.0.
Market Sentiment: 0.2
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
NUF NUFARM LIMITED
Agriculture – Overnight Price: $4.58
Moelis rates ((NUF)) as Hold (3) –
Nufarm has delivered a solid full year result despite a challenging environment, says Moelis, with group earnings down -2% year-on-year. Crop protection earnings tumbled -9%, a result of margin compression from lower ingredient prices, while seed technology earnings lifted 67%.
The broker points out the second half was a challenging period for crop protection, with a global oversupply driving channel destocking alongside the sharp reduction in active ingredient prices. The company is warning of another challenging period in the first half.
The Hold rating is retained and the target price increases to $5.40 from $5.01.
This report was published on November 15, 2023.
Target price is $5.40 Current Price is $4.58 Difference: $0.82
If NUF meets the Moelis target it will return approximately 18% (excluding dividends, fees and charges).
Current consensus price target is $6.10, suggesting upside of 35.9%(ex-dividends)
The company's fiscal year ends in September.
Forecast for FY24:
Moelis forecasts a full year FY24 dividend of 10.80 cents and EPS of 31.40 cents.
At the last closing share price the estimated dividend yield is 2.36%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 14.59.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 34.8, implying annual growth of 32.5%.
Current consensus DPS estimate is 10.2, implying a prospective dividend yield of 2.3%.
Current consensus EPS estimate suggests the PER is 12.9.
Forecast for FY25:
Moelis forecasts a full year FY25 dividend of 12.30 cents and EPS of 37.20 cents.
At the last closing share price the estimated dividend yield is 2.69%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 12.31.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 44.6, implying annual growth of 28.2%.
Current consensus DPS estimate is 13.0, implying a prospective dividend yield of 2.9%.
Current consensus EPS estimate suggests the PER is 10.1.
Market Sentiment: 0.7
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
NWC NEW WORLD RESOURCES LIMITED
Copper – Overnight Price: $0.04
Petra Capital rates ((NWC)) as Buy (1) –
This quarter, New World Resources has restarted drilling at its Antler Copper Project; purchased extra rights at Antler; received $11m in NSR royalty funding and announced high-grade chip assay results at Javelin observes Petra Capital.
The broker says the company has sufficient funds to lift the pace on drilling and resource expansion. The $11m has substantially boosted the balance sheet, observes the broker.
Buy rating retained, the broker observing the company is trading at a deep discount to peers. Target price is 12c, which compares with 14c in May.
This report was published on November 13, 2023.
Target price is $0.12 Current Price is $0.04 Difference: $0.082
If NWC meets the Petra Capital target it will return approximately 216% (excluding dividends, fees and charges).
The company's fiscal year ends in June.
Forecast for FY24:
Petra Capital forecasts a full year FY24 dividend of 0.00 cents and EPS of minus 0.10 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 38.00.
Forecast for FY25:
Petra Capital forecasts a full year FY25 dividend of 0.00 cents and EPS of minus 0.10 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 38.00.
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
OFX OFX GROUP LIMITED
Diversified Financials – Overnight Price: $1.39
Canaccord Genuity rates ((OFX)) as Buy (1) –
OFX Group's September half result missed Canaccord Genuity's forecasts, and EBITDA margins fell to 25% from 29% in the previous corresponding period.
Management shaved the top end of net operating income guidance.
The broker retains the faith, observing the company is trading on an undemanding multiple and expects an improvement in the June half and FY25 as corporate normalises, higher net interest income flows in and synergies from Firma kick in.
Add the potential for further accretive acquisitions, improved pricing and the fact the stock is trading at record lows, and the broker is of the opinion that the share price must rise from here.
Buy rating retained. Target price falls to $2.20 from $2.65.
This report was published on November 15, 2023.
Target price is $2.20 Current Price is $1.39 Difference: $0.815
If OFX meets the Canaccord Genuity target it will return approximately 59% (excluding dividends, fees and charges).
The company's fiscal year ends in March.
Forecast for FY24:
Canaccord Genuity forecasts a full year FY24 dividend of 0.00 cents and EPS of 11.00 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 12.59.
Forecast for FY25:
Canaccord Genuity forecasts a full year FY25 dividend of 0.00 cents and EPS of 14.00 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 9.89.
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Wilsons rates ((OFX)) as Overweight (1) –
While OFX Group reported turnover of $19.2bn in the first half, a -4% decline on the previous comparable period, Wilsons feels the company did well cycling a challening prior half.
It is expected that pricing, higher interest income and a more balanced cost-growth profile can drive earnings improvements. Some softness in corporate activity in the second quarter has normalised, and Wilsons continues to see upside to the share price.
The Overweight rating is retained and the target price decreases to $2.17 from $2.35.
This report was published on November 15, 2023.
Target price is $2.17 Current Price is $1.39 Difference: $0.785
If OFX meets the Wilsons target it will return approximately 57% (excluding dividends, fees and charges).
The company's fiscal year ends in March.
Forecast for FY24:
Wilsons forecasts a full year FY24 dividend of 0.00 cents and EPS of 13.60 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 10.18.
Forecast for FY25:
Wilsons forecasts a full year FY25 dividend of 0.00 cents and EPS of 14.60 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 9.49.
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
REG REGIS HEALTHCARE LIMITED
Aged Care & Seniors – Overnight Price: $2.79
Moelis rates ((REG)) as Buy (1) –
In a move that Moelis believes highlights the deep sector consolidation opportunity available to Regis Healthcare, the company is set to acquire five aged care homes in Queensland at a cost of -$74.2m.
The homes boast a 96% occupancy rate and delivered $13m in earnings in FY23. The broker sees potential for Regis Healthcare to explore similar acquisitions in coming years, noting the company should hold more than $120m in debt capacity following this purchase.
The Buy rating is retained and the target price increases to $3.38 from $3.00.
This report was published on November 15, 2023.
Target price is $3.38 Current Price is $2.79 Difference: $0.59
If REG meets the Moelis target it will return approximately 21% (excluding dividends, fees and charges).
The company's fiscal year ends in June.
Forecast for FY24:
Moelis forecasts a full year FY24 dividend of 9.50 cents and EPS of 9.70 cents.
At the last closing share price the estimated dividend yield is 3.41%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 28.76.
Forecast for FY25:
Moelis forecasts a full year FY25 dividend of 11.50 cents and EPS of 11.80 cents.
At the last closing share price the estimated dividend yield is 4.12%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 23.64.
Market Sentiment: 0.8
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
RHC RAMSAY HEALTH CARE LIMITED
Healthcare services – Overnight Price: $50.09
Jarden rates ((RHC)) as Neutral (3) –
Ramsay Health Care is proposing to sell its Ramsay Sime-Darby joint venture for $2bn. Any fears of a capital raising have now been sidelined, suggests Jarden, with net proceeds of $935m to be deployed against debt.
The broker's target price would have increased by 2.9% as a result of the sale, were it not for an increase in Jarden's assumed risk-free rate. The target falls to $58 from $62.08.
The Neutral rating is maintained.
This report was published on November 14, 2023.
Target price is $58.00 Current Price is $50.09 Difference: $7.91
If RHC meets the Jarden target it will return approximately 16% (excluding dividends, fees and charges).
Current consensus price target is $57.07, suggesting upside of 14.0%(ex-dividends)
The company's fiscal year ends in June.
Forecast for FY24:
Jarden forecasts a full year FY24 dividend of 244.10 cents and EPS of 133.10 cents.
At the last closing share price the estimated dividend yield is 4.87%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 37.63.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 142.0, implying annual growth of 13.5%.
Current consensus DPS estimate is 89.0, implying a prospective dividend yield of 1.8%.
Current consensus EPS estimate suggests the PER is 35.3.
Forecast for FY25:
Jarden forecasts a full year FY25 dividend of 139.90 cents and EPS of 232.50 cents.
At the last closing share price the estimated dividend yield is 2.79%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 21.54.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 206.9, implying annual growth of 45.7%.
Current consensus DPS estimate is 124.8, implying a prospective dividend yield of 2.5%.
Current consensus EPS estimate suggests the PER is 24.2.
Market Sentiment: 0.3
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Wilsons rates ((RHC)) as Market Weight (3) –
A tour of Ramsay Health Care's Gold coast and Brisbane hospitals appears to have pleased Wilsons, the broker believing on-the-ground observations support its volume expectations.
Ramsay Health Care and Asian partner Sime-Darby have signed a deal to sell their Asian JV for $2.0bn, which Wilsons expects will deliver a one-off $632m windfall to Ramsay's June-half net profit after tax.
EPS forecasts rise 5% to 7% to reflect likely debt reduction.
Market Weight rating and $50 target price retained.
This report was published on November 13, 2023.
Target price is $50.00 Current Price is $50.09 Difference: minus $0.09 (current price is over target).
If RHC meets the Wilsons target it will return approximately minus 0% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $57.07, suggesting upside of 14.0%(ex-dividends)
The company's fiscal year ends in June.
Forecast for FY24:
Wilsons forecasts a full year FY24 dividend of 94.30 cents and EPS of 150.00 cents.
At the last closing share price the estimated dividend yield is 1.88%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 33.39.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 142.0, implying annual growth of 13.5%.
Current consensus DPS estimate is 89.0, implying a prospective dividend yield of 1.8%.
Current consensus EPS estimate suggests the PER is 35.3.
Forecast for FY25:
Wilsons forecasts a full year FY25 dividend of 130.10 cents and EPS of 207.80 cents.
At the last closing share price the estimated dividend yield is 2.60%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 24.10.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 206.9, implying annual growth of 45.7%.
Current consensus DPS estimate is 124.8, implying a prospective dividend yield of 2.5%.
Current consensus EPS estimate suggests the PER is 24.2.
Market Sentiment: 0.3
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
RUL RPMGLOBAL HOLDINGS LIMITED
Mining Sector Contracting – Overnight Price: $1.52
Moelis rates ((RUL)) as Buy (1) –
RPMGlobal has received $3.1m following change of control to a contract counterparty in a software agreement.
FY24 guidance is raised to $110m to $115m from $107m to $112m.
The broker makes minimal changes to forecasts given the payment is a one-off, although EPS forecasts rise.
Buy rating retained. Target price edges up to $2.04 from $2.03.
This report was published on November 13, 2023.
Target price is $2.04 Current Price is $1.52 Difference: $0.52
If RUL meets the Moelis target it will return approximately 34% (excluding dividends, fees and charges).
The company's fiscal year ends in June.
Forecast for FY24:
Moelis forecasts a full year FY24 dividend of 0.00 cents and EPS of 5.00 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 30.41.
Forecast for FY25:
Moelis forecasts a full year FY25 dividend of 0.00 cents and EPS of 5.54 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 27.44.
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
SDV SCIDEV LIMITED
Industrial Sector Contractors & Engineers – Overnight Price: $0.24
Canaccord Genuity rates ((SDV)) as Speculative Buy (1) –
SciDev's September-quarter trading update disappointed Canaccord Genuity, due to the company's transition from commoditised chemical sales to more consistent recurring revenue streams.
But the broker retains the faith, observing the company is well placed to take advantage of strong ESG tailwinds as water regulations tighten.
The broker appreciates the company's large addressable market, margin support from its growing build-own-operate pipeline, stabilisation of growth and big recurring revenue base.
Speculative Buy rating retained. Target price falls to 40c from 50c.
This report was published on November 14, 2023.
Target price is $0.40 Current Price is $0.24 Difference: $0.16
If SDV meets the Canaccord Genuity target it will return approximately 67% (excluding dividends, fees and charges).
The company's fiscal year ends in June.
Forecast for FY24:
Canaccord Genuity forecasts a full year FY24 dividend of 0.00 cents and EPS of minus 0.20 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 120.00.
Forecast for FY25:
Canaccord Genuity forecasts a full year FY25 dividend of 0.00 cents and EPS of minus 0.10 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 240.00.
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
STX STRIKE ENERGY LIMITED
NatGas – Overnight Price: $0.39
Wilsons rates ((STX)) as Overweight (1) –
Strike Energy's South Erregulla development has recieved its primary environmental approval, completing the primary government approvals process required prior to finalising a final investment decision.
Wilsons notes the approval is an important milestone, and delivery consistent with the expected timeline for the project. The broker points out Strike Energy may commit long term leads before delivering a final investment decision, in order to achieve first gas in early 2024.
The Overweight rating and target price of 54 cents are retained.
This report was published on November 14, 2023.
Target price is $0.54 Current Price is $0.39 Difference: $0.15
If STX meets the Wilsons target it will return approximately 38% (excluding dividends, fees and charges).
Current consensus price target is $0.54, suggesting upside of 38.5%(ex-dividends)
The company's fiscal year ends in June.
Forecast for FY24:
Wilsons forecasts a full year FY24 dividend of 0.00 cents and EPS of 0.50 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 78.00.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 0.5, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 78.0.
Forecast for FY25:
Wilsons forecasts a full year FY25 dividend of 0.00 cents and EPS of 1.80 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 21.67.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 1.5, implying annual growth of 200.0%.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 26.0.
Market Sentiment: 0.7
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
SUN SUNCORP GROUP LIMITED
Insurance – Overnight Price: $13.49
Jarden rates ((SUN)) as Buy (1) –
Suncorp Group's Q1 Banking Division update revealed a slowdown in housing lending with negative growth of -0.1% following 3.7% growth over the 2H of FY23, explains Jarden.
The business loan book (smaller than the housing book), which represents 19% of total lending, points out the broker, also returned negative growth of -0.9% in Q1.
The quarterly net interest margin (NIM) was not disclosed, with management noting "pricing on both lending and deposits continues to reflect the intensely competitive environment, with ongoing pressure on net interest margin".
Jarden's Buy rating and $15.25 target are maintained.
This report was published on November 10, 2023.
Target price is $15.25 Current Price is $13.49 Difference: $1.76
If SUN meets the Jarden target it will return approximately 13% (excluding dividends, fees and charges).
Current consensus price target is $15.23, suggesting upside of 11.6%(ex-dividends)
The company's fiscal year ends in June.
Forecast for FY24:
Jarden forecasts a full year FY24 dividend of 69.00 cents and EPS of 107.70 cents.
At the last closing share price the estimated dividend yield is 5.11%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 12.53.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 107.2, implying annual growth of 17.9%.
Current consensus DPS estimate is 74.7, implying a prospective dividend yield of 5.5%.
Current consensus EPS estimate suggests the PER is 12.7.
Forecast for FY25:
Jarden forecasts a full year FY25 dividend of 122.60 cents and EPS of 107.30 cents.
At the last closing share price the estimated dividend yield is 9.09%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 12.57.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 111.7, implying annual growth of 4.2%.
Current consensus DPS estimate is 85.6, implying a prospective dividend yield of 6.3%.
Current consensus EPS estimate suggests the PER is 12.2.
Market Sentiment: 0.8
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
TLS TELSTRA GROUP LIMITED
Telecommunication – Overnight Price: $3.82
Goldman Sachs rates ((TLS)) as Buy (1) –
While Goldman Sachs lowers EPS forecasts only marginally, following Telstra Group's investor day, the FY25 and FY26 DPS forecasts fall to 19c and 20c, respectively, from 20c and 22c.
The lower dividend forecasts are due to higher expected capex spending on fibre on top of minor earnings downgrades, explains the broker.
Management reiterated key 2025 financial targets and FY24 guidance, and the broker notes Mobile strength continues into FY24 with price-rise induced churn now beginning to normalise. It's also felt the company is benefiting from the recent Optus network outage.
The $4.70 target and Buy rating are unchanged.
This report was published on November 15, 2023.
Target price is $4.70 Current Price is $3.82 Difference: $0.88
If TLS meets the Goldman Sachs target it will return approximately 23% (excluding dividends, fees and charges).
Current consensus price target is $4.42, suggesting upside of 15.6%(ex-dividends)
The company's fiscal year ends in June.
Forecast for FY24:
Goldman Sachs forecasts a full year FY24 dividend of 18.00 cents and EPS of 18.00 cents.
At the last closing share price the estimated dividend yield is 4.71%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 21.22.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 18.1, implying annual growth of 8.4%.
Current consensus DPS estimate is 17.8, implying a prospective dividend yield of 4.7%.
Current consensus EPS estimate suggests the PER is 21.1.
Forecast for FY25:
Goldman Sachs forecasts a full year FY25 dividend of 19.00 cents and EPS of 19.00 cents.
At the last closing share price the estimated dividend yield is 4.97%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 20.11.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 19.8, implying annual growth of 9.4%.
Current consensus DPS estimate is 18.6, implying a prospective dividend yield of 4.9%.
Current consensus EPS estimate suggests the PER is 19.3.
Market Sentiment: 0.6
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Jarden rates ((TLS)) as Buy (1) –
Telstra Group has confirmed at its investor day that it is on track to hit its financial targets under its T25 strategy of single digit EBITDA compound annual growth and high-teens EPS CAGR for FY21-FY25.
The company advises that it will also reach the bulk of its T25 planned cost savings.
Jarden believes success will result in incremental EBITDA growth of $500m from FY24 to FY25, not included in consensus forecasts, hence the broker's valuation sits above consensus.
Buy rating retained and $4.30 target price retained.
This report was published on November 14, 2023.
Target price is $4.30 Current Price is $3.82 Difference: $0.48
If TLS meets the Jarden target it will return approximately 13% (excluding dividends, fees and charges).
Current consensus price target is $4.42, suggesting upside of 15.6%(ex-dividends)
The company's fiscal year ends in June.
Forecast for FY24:
Jarden forecasts a full year FY24 dividend of 17.00 cents and EPS of 17.50 cents.
At the last closing share price the estimated dividend yield is 4.45%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 21.83.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 18.1, implying annual growth of 8.4%.
Current consensus DPS estimate is 17.8, implying a prospective dividend yield of 4.7%.
Current consensus EPS estimate suggests the PER is 21.1.
Forecast for FY25:
Jarden forecasts a full year FY25 dividend of 19.00 cents and EPS of 19.90 cents.
At the last closing share price the estimated dividend yield is 4.97%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 19.20.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 19.8, implying annual growth of 9.4%.
Current consensus DPS estimate is 18.6, implying a prospective dividend yield of 4.9%.
Current consensus EPS estimate suggests the PER is 19.3.
Market Sentiment: 0.6
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
TPG TPG TELECOM LIMITED
Telecommunication – Overnight Price: $4.74
Jarden rates ((TPG)) as Upgrade to Buy from Overweight (1) –
The cessation of discussions to sell TPG Telecom's non-mobile fibre assets to Vocus group doesn't impact Jarden's investment thesis on TPG Telecom. It's felt the -12% share sell-off on November 13 presented a more attractive entry point.
The $5.40 target is unchanged, and the broker upgraded the rating to Buy from Overweight on valuation.
Management noted ongoing interest in the company's fixed infrastructure assets from financial and strategic buyers.
This report was published on November 14, 2023.
Target price is $5.40 Current Price is $4.74 Difference: $0.66
If TPG meets the Jarden target it will return approximately 14% (excluding dividends, fees and charges).
Current consensus price target is $5.88, suggesting upside of 23.9%(ex-dividends)
The company's fiscal year ends in December.
Forecast for FY23:
Jarden forecasts a full year FY23 dividend of 18.00 cents and EPS of 5.80 cents.
At the last closing share price the estimated dividend yield is 3.80%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 81.72.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 16.1, implying annual growth of -41.7%.
Current consensus DPS estimate is 18.5, implying a prospective dividend yield of 3.9%.
Current consensus EPS estimate suggests the PER is 29.4.
Forecast for FY24:
Jarden forecasts a full year FY24 dividend of 19.00 cents and EPS of 9.40 cents.
At the last closing share price the estimated dividend yield is 4.01%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 50.43.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 18.7, implying annual growth of 16.1%.
Current consensus DPS estimate is 20.0, implying a prospective dividend yield of 4.2%.
Current consensus EPS estimate suggests the PER is 25.3.
Market Sentiment: 0.1
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Disclaimer:
The content of this information does in no way reflect the opinions of FNArena, or of its journalists. In fact we don't have any opinion about the stock market, its value, future direction or individual shares. FNArena solely reports about what the main experts in the market note, believe and comment on. By doing so we believe we provide experienced, intelligent investors with a valuable tool that helps them in making up their own minds, reading market trends and getting a feel for what is happening beneath the surface.
This document is provided for informational purposes only. It does not constitute an offer to sell or a solicitation to buy any security or other financial instrument. FNArena employs very experienced journalists who base their work on information believed to be reliable and accurate, though no guarantee is given that the daily report is accurate or complete. Investors should contact their personal adviser before making any investment decision.
Decisions about inclusions in this Report are made independently of the providers of stock market research and at full discretion of the team of journalists responsible for content at FNArena. Inclusion does not equal endorsement, in any way, shape or form. This Report is provided for informational purposes only.
Click to view our Glossary of Financial Terms
CHARTS
For more info SHARE ANALYSIS: A11 - ATLANTIC LITHIUM LIMITED.
For more info SHARE ANALYSIS: ABB - AUSSIE BROADBAND LIMITED
For more info SHARE ANALYSIS: ALL - ARISTOCRAT LEISURE LIMITED
For more info SHARE ANALYSIS: ALQ - ALS LIMITED
For more info SHARE ANALYSIS: ANZ - ANZ GROUP HOLDINGS LIMITED
For more info SHARE ANALYSIS: BLD - BORAL LIMITED
For more info SHARE ANALYSIS: BRG - BREVILLE GROUP LIMITED
For more info SHARE ANALYSIS: CAI - CALIDUS RESOURCES LIMITED
For more info SHARE ANALYSIS: CAT - CATAPULT GROUP INTERNATIONAL LIMITED
For more info SHARE ANALYSIS: CBA - COMMONWEALTH BANK OF AUSTRALIA
For more info SHARE ANALYSIS: CSL - CSL LIMITED
For more info SHARE ANALYSIS: CTM - CENTAURUS METALS LIMITED
For more info SHARE ANALYSIS: DGL - DGL GROUP LIMITED
For more info SHARE ANALYSIS: DYL - DEEP YELLOW LIMITED
For more info SHARE ANALYSIS: ELD - ELDERS LIMITED
For more info SHARE ANALYSIS: IGO - IGO LIMITED
For more info SHARE ANALYSIS: IPL - INCITEC PIVOT LIMITED
For more info SHARE ANALYSIS: LIC - LIFESTYLE COMMUNITIES LIMITED
For more info SHARE ANALYSIS: MHJ - MICHAEL HILL INTERNATIONAL LIMITED
For more info SHARE ANALYSIS: MRM - MMA OFFSHORE LIMITED
For more info SHARE ANALYSIS: MTS - METCASH LIMITED
For more info SHARE ANALYSIS: NHF - NIB HOLDINGS LIMITED
For more info SHARE ANALYSIS: NST - NORTHERN STAR RESOURCES LIMITED
For more info SHARE ANALYSIS: NUF - NUFARM LIMITED
For more info SHARE ANALYSIS: NWC - NEW WORLD RESOURCES LIMITED
For more info SHARE ANALYSIS: OFX - OFX GROUP LIMITED
For more info SHARE ANALYSIS: QAN - QANTAS AIRWAYS LIMITED
For more info SHARE ANALYSIS: REG - REGIS HEALTHCARE LIMITED
For more info SHARE ANALYSIS: RHC - RAMSAY HEALTH CARE LIMITED
For more info SHARE ANALYSIS: RUL - RPMGLOBAL HOLDINGS LIMITED
For more info SHARE ANALYSIS: SDV - SCIDEV LIMITED
For more info SHARE ANALYSIS: STX - STRIKE ENERGY LIMITED
For more info SHARE ANALYSIS: SUN - SUNCORP GROUP LIMITED
For more info SHARE ANALYSIS: SYM - SYMBIO HOLDINGS LIMITED
For more info SHARE ANALYSIS: TLS - TELSTRA GROUP LIMITED
For more info SHARE ANALYSIS: TPG - TPG TELECOM LIMITED